Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-08

Clinical Trial Update: Impact of Madecassoside and 5 % Panthenol Cream in Post Photodynamic Therapy for Actinic Keratosis [NA]

View source ↗

Summary

A completed clinical trial evaluated the impact of applying Madecassoside and 5% panthenol cream after photodynamic therapy for actinic keratosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Madecassoside (madecassoside)
  • Panthenol cream (5%) (panthenol)

Snippet

Sponsor: Merete Haedersdal | Conditions: Actinic Keratoses | NA | Status: COMPLETED